WallStSmart

LightPath Technologies Inc (LPTH)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Zepp Health Corp generates 390% more annual revenue ($258.90M vs $52.79M). ZEPP leads profitability with a -15.5% profit margin vs -43.4%. ZEPP earns a higher WallStSmart Score of 41/100 (D).

LPTH

Hold

41

out of 100

Grade: D

Growth: 8.0Profit: 2.0Value: 4.7Quality: 6.5
Piotroski: 2/9Altman Z: -3.56

ZEPP

Hold

41

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for LPTH.

ZEPPUndervalued (+48.6%)

Margin of Safety

+48.6%

Fair Value

$46.70

Current Price

$17.47

$29.23 discount

UndervaluedFair: $46.70Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

LPTH3 strengths · Avg: 9.7/10
Revenue GrowthGrowth
120.2%10/10

Revenue surging 120.2% year-over-year

EPS GrowthGrowth
4911.0%10/10

Earnings expanding 4911.0% YoY

Debt/EquityHealth
0.139/10

Conservative balance sheet, low leverage

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

LPTH4 concerns · Avg: 3.5/10
PEG RatioValuation
1.544/10

Expensive relative to growth rate

Price/BookValuation
9.0x4/10

Trading at 9.0x book value

Market CapQuality
$807.34M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$247.54M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-15.5%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : LPTH

The strongest argument for LPTH centers on Revenue Growth, EPS Growth, Debt/Equity. Revenue growth of 120.2% demonstrates continued momentum.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : LPTH

The primary concerns for LPTH are PEG Ratio, Price/Book, Market Cap.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

ZEPP carries more volatility with a beta of 1.77 — expect wider price swings.

LPTH is growing revenue faster at 120.2% — sustainability is the question.

Monitor ELECTRONIC COMPONENTS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

LPTH scores higher overall (41/100 vs 41/100) and 120.2% revenue growth. ZEPP offers better value entry with a 48.6% margin of safety. Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

LightPath Technologies Inc

TECHNOLOGY · ELECTRONIC COMPONENTS · USA

LightPath Technologies, Inc. designs, develops, manufactures and distributes optical components and assemblies. The company is headquartered in Orlando, Florida.

Visit Website →

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?